Media Coverage

Kansas and Missouri universities in One Health pact

Jun 30, 2017 - Animal Pharm
By Joseph Harvey
Animal Pharm
June 30, 2017 

Kansas State University's Olathe and Manhattan campuses have combined with the University of Missouri-Kansas City to establish 1Data – a project designed to accelerate breakthroughs in human and animal health.

The partnership will look to establish a new standard for analyzing cross-species health information, while it also aims to reduce the cost of drug development by bringing the two sectors closer together.

Jim Riviere, distinguished professor emeritus at Kansas State University's College of Veterinary Medicine, and Gerald Wyckoff, professor of molecular biology and biochemistry at the University of Missouri-Kansas City, will oversee 1Data. The project is situated at the K-State Olathe campus.

Prof Riviere said: "Right now, research labs and human and animal health companies are all doing the exact same trials with the same animal patients, but they're not sharing the data and learning from it to help with future trials. Redoing the same study or part of a study over and over wastes time, money and involves unnecessary animal models. We would like to change that."

1Data has received funding from a varied range of backers, including Elanco, while Aratana Therapeutics is a collaborating partner. Elanco's president Jeff Simmons recently urged the animal health industry to get into the tailwind of One Health.

The academic partners stated: "1Data aggregates an array of pre-clinical human and animal health information into a cohesive, structured and open-source database called the Structured Environment for Animal Data and Simulation.

"Once aggregated, data is evaluated and standardized to enable them to be mined for specific information. Under this framework, researchers will develop a clearinghouse platform for the collection and integration of multiple databases to create the next generation of approaches to curing or mitigating human and animal diseases.

"1Data will help scientists fully simulate the design of animal models and identify congruencies between human and animal diseases."

Reprinted with permission of Animal Pharm News




News Releases

Inside the Corridor

KC Animal Health Blog

Investment Forum